Efficacy and safety of monotherapy of sitagliptin compared with metformin in patients with type 2 diabetes-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and safety of monotherapy of sitagliptin compared with metformin in patients with type 2 diabetes

Published:2010-03 Issue:3 Volume:12 Page:252-261
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:

Author:

Aschner P.,Katzeff H. L.,Guo H.,Sunga S.,Williams-Herman D.,Kaufman K. D.,Goldstein B. J.,

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1463-1326.2009.01187.x/fullpdf

Reference24 articles.

1. Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes;Nathan;Diabetes Care,2006

2. New combination treatments in the management of diabetes: focus on sitagliptin-metformin;Green;Vasc Health Risk Manag,2008

3. Metformin therapy and clinical uses;Scarpello;Diab Vasc Dis Res,2008

4. Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy on glycemic control in patients with type 2 diabetes;Aschner;Diabetes Care,2006

5. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy in patients with type 2 diabetes mellitus;Raz;Diabetologia,2006

Cited by 134 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Does metformin reduce the risk of cancer in obesity and diabetes? A systematic review and meta‐analysis;Diabetes, Obesity and Metabolism;2024-02-23

2. Beta‐cell function in type 2 diabetes (T2DM): Can it be preserved or enhanced?;Journal of Diabetes;2023-07-31

3. Total fibre vs types and sources of fibre in subjects with and without diabetes: Role of molecular weight and viscosity;Bioactive Carbohydrates and Dietary Fibre;2023-05

4. Diabetes Technology and Therapy in the Pediatric Age Group;Diabetes Technology & Therapeutics;2023-02-01

5. Regulation of Adropin by Sitagliptin monotherapy in participants with newly diagnosed type 2 Diabetes;BMC Endocrine Disorders;2022-12-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3